Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD.

Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.

PMID:
19047240
2.

Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

Drugs. 2010 Jun 18;70(9):1165-88. doi: 10.2165/11205030-000000000-00000. Review.

PMID:
20518582
3.

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.

Ciarlet M, Schödel F.

Vaccine. 2009 Dec 30;27 Suppl 6:G72-81. doi: 10.1016/j.vaccine.2009.09.107. Review.

PMID:
20006144
4.

RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.

Chandran A, Santosham M.

Expert Rev Vaccines. 2008 Dec;7(10):1475-80. doi: 10.1586/14760584.7.10.1475. Review.

PMID:
19053204
5.

Rotavirus overview.

Bernstein DI.

Pediatr Infect Dis J. 2009 Mar;28(3 Suppl):S50-3. doi: 10.1097/INF.0b013e3181967bee. Review.

PMID:
19252423
6.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
7.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
8.

First rotavirus vaccine licensed: is there really a need?

Glass RI, Bresee JS, Parashar UD, Holman RC, Gentsch JR.

Acta Paediatr Suppl. 1999 Jan;88(426):2-8. Review.

PMID:
10088904
9.

Effects of vaccine on rotavirus disease in the pediatric population.

Dennehy PH.

Curr Opin Pediatr. 2012 Feb;24(1):76-84. doi: 10.1097/MOP.0b013e32834ee594. Review.

PMID:
22189398
10.

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.

Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S56-60. doi: 10.1097/INF.0b013e3181fefdc0. Review.

PMID:
21183842
11.

Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.

Bresee JS, Hummelman E, Nelson EA, Glass RI.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S1-5. Review. No abstract available.

12.

Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA.

Hum Vaccin. 2011 Jul;7(7):734-48. doi: 10.4161/hv.7.7.15511. Epub 2011 Jul 1. Review.

PMID:
21734466
13.

Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease.

Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z, Giaquinto C, Grimprel E.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S12-21. Review.

PMID:
16397425
14.

Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review.

Kawai K, O'Brien MA, Goveia MG, Mast TC, El Khoury AC.

Vaccine. 2012 Feb 8;30(7):1244-54. doi: 10.1016/j.vaccine.2011.12.092. Epub 2011 Dec 31. Review.

PMID:
22212128
15.

The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines.

Kane EM, Turcios RM, Arvay ML, Garcia S, Bresee JS, Glass RI.

Rev Panam Salud Publica. 2004 Dec;16(6):371-7. Review.

PMID:
15673479
16.

Rotavirus infection and the current status of rotavirus vaccines.

Chen SC, Tan LB, Huang LM, Chen KT.

J Formos Med Assoc. 2012 Apr;111(4):183-93. doi: 10.1016/j.jfma.2011.09.024. Epub 2012 Mar 29. Review.

17.

The epidemiology of rotavirus diarrhea in countries in the Eastern Mediterranean Region.

Malek MA, Teleb N, Abu-Elyazeed R, Riddle MS, Sherif ME, Steele AD, Glass RI, Bresee JS.

J Infect Dis. 2010 Sep 1;202 Suppl:S12-22. doi: 10.1086/653579. Review.

18.

Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Grimwood K, Lambert SB, Milne RJ.

Paediatr Drugs. 2010 Aug 1;12(4):235-56. doi: 10.2165/11537200-000000000-00000. Review.

PMID:
20593908
19.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

20.

Rotavirus vaccine (RotaTeq).

Keating GM.

Paediatr Drugs. 2006;8(3):197-202; discussion 203-4. Review.

PMID:
16774301
Items per page

Supplemental Content

Write to the Help Desk